Scientists use ML to find an antibiotic able to kill superbugs in mice
> That is an especially pressing challenge in the development of new antibiotics, because a lack of economic incentives has caused pharmaceutical companies to pull back from the search for badly needed treatments. Each year in the U.S., drug-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths, with more than a third of fatalities attributable to C. diff, according to the the Centers for Disease Control and Prevention.<p>How big does the market have to be to commercially viable for research and development? Nearly 3M potential patients at a couple hundred dollars per course is nearing a $1B/year.